Xepa – Soul Pattinson | Leading Manufacturer of Off-Patent Pharmaceuticals

Who We Are

Founded in 1967 in Singapore, Xepa has grown and evolved at the cutting edge of the industry. From our modest first years when Xepa Laboratories Pte. Ltd. produced a limited range of pharmaceutical products in a small flatted factory, we have relocated twice to larger manufacturing plants in Melaka, Malaysia. Today, Xepa is a leading manufacturer of off-patent pharmaceutical products in Malaysia.

Quick Facts More than 50 Years
of Leadership
50+
Quick Facts Manufacturing Facilities
in One Campus
4
Quick Facts Dedicated Employees 450+
Quick Facts Marketed Products 100+
Quick Facts Global Presence 21

what we do

What We Do

Develop

We invest in scientific and technical excellence to develop new products that meet patient needs. 

Manufacture

We are committed to robust quality controls and high manufacturing standards.

Market

As part of our efforts to increase patient access to quality medicine, our sales and marketing teams thrive to expand our product outreach within Malaysia and abroad.

our core values

Our Core Values

Leadership/
Pioneering Spirit

We will continue to strengthen the leadership and pioneering spirit established by our founders by striving to lead the industry in all aspects.

Integrity

We uphold customers’ trust built by our founders in our products and we strive to maintain the highest ethical standards. We act with integrity in all manner of dealings.

Teamwork
& Respect

We work as a team to achieve shared company objectives irrespective of our backgrounds. We respect and value everyone’s opinions and feedback.

Continuous Improvement

We stay ahead in a highly competitive market and maintain our leadership position. We continue to innovate to meet the future needs of the market and customers.

Innovation

We value ideas and innovations from all corners of our operations and continue to break new grounds.

our plant

Our Plant

  • Located at Cheng Industrial Estate, Melaka, Malaysia.
  • 38,249 sq metres built-up area
  • 7 facilities including laboratories, liquids production plant, solids production plants, warehouse and offices.
  • Spread over a 10-acre site

SPP NOVO

The latest Oral Solid Dosage manufacturing plant was completed in the last quarter of 2018 and received regulatory approval for commercial production on 16th May 2019.

Its built-up area of 19,406 sq metres is a vital infrastructure that enables Xepa to enhance its manufacturing capability and capacity while meeting stringent certifications.

Product Lines

Xepa produces a wide range of dosage forms.

tablet
Tablets
capsules
Capsules
creams
Creams & Ointments
Liquid
Liquids
powder
Powder for Oral Suspensions
drops
Sterile Eye Drops

accreditation

Accreditation  

EU GMP

European Union Good Manufacturing Practice

In year 2017, Xepa was awarded EU GMP Certificate by the national competent authority of Hungary in European Union.

The scope of the EU GMP certification encompasses the manufacturing of sterile (eye drops) and non-sterile products (solids, semi-solids and liquids), packaging (both primary and secondary) and quality control testing (microbiological and chemical/physical) of human medicinal products.

PIC/s GMP

Pharmaceutical Inspection Co-operation Scheme Good Manufacturing Practice

TGA GMP

Therapeutic Goods Administration (TGA) GMP Clearance (Non-sterile Dosage Forms)

EN ISO 13485:2016

Certification for Manufacturing of Medical Devices (European Standards)

ISO/IEC 17025:2017

Certification for Analytical Laboratory

ISO9001:2015

Certification for Quality Management System

GDPMD

Good Distribution Practice for Medical Devices

global presence

Global Presence
 

Xepa’s products are exported to countries in Asia Pacific, Africa and Middle East.

  • Malaysia
  • Singapore
  • Vietnam
  • Myanmar
  • Hong Kong
  • Taiwan
  • Macau
  • Japan
  • Australia
  • Philippines
  • Cambodia
  • Brunei
  • Maldives
  • Fiji
  • Tonga
  • Mauritius
  • Kenya
  • Uganda
  • Nigeria
  • Iraq
  • Yemen

helping people

to live healthier, longer and more productive lives.

Helping People

Xepa-Soul Pattinson constantly strives to make a positive impact in people’s lives by producing high quality and affordable medicines. We pursue a Corporate Social Responsibility (CSR) programme that extends our reach to our local communities with the same intent: helping people to live healthier, longer and more productive lives.

Our CSR policy comprises four core thrusts: People, Society, Environment and Governance. Guided by these pillars, we nurture and foster a spirit of community and volunteerism that promotes the virtue of placing others before self.

Empowering Lives

Training & Development

People are the cornerstone of our business. As an employer of choice, we seek to drive a strong learning culture through continuous training and development programs to help our people reach their full potential.

Training for Provisionally Registered Pharmacist (PRP)

Xepa is also recognised by the Pharmacy Board Malaysia as one of the Training Premises for Provisionally Registered Pharmacist (PRP). The PRPs are exposed to various areas relevant to pharmacy practice. This accreditation further consolidates our commitment to provide training and development for junior pharmacists in their pursuit of professional excellence.

Employee Health and Safety

We instil a culture of safety to achieve a zero-harm workplace.  We improve employee well-being through programs such as Health Education, Health Check, Emergency Response Team (ERT) Bomba Training and various talks on safety measure.

.

Nurturing Communities

 

Improving Patient Access to High Quality Medicine

Xepa is a leading provider of pharmaceuticals to hospital, clinics and pharmacies with strong presence in Southeast Asia. We continuously strive to expand our footprint to serve and deliver the highest quality products affordably to as many people as possible.

Improving Patient Outcomes Through Education

In Xepa, we aspire to optimize patient outcomes by implementing medical education activities – SHINE (Supporting Healthcare Improvement & Nurturing Excellence). The program aims to increase awareness and management of various ailments including respiratory and dermatological conditions to achieve better diagnosis and patient outcomes.

Charitable Giving

We are committed to supporting communities by investing our resources in programs that address some of the biggest social challenges.

We help empower our local communities to thrive and to make a positive, lasting impact for the underserved.

Educational Grants

Xepa supports various educational grants to pharmacy undergraduates because we believe that education brings about positive change in the lives of individuals.

Blood Donation Drive

Xepa holds blood donation drives to meet the growing demands of blood nationally. This is part of Xepa’s Corporate Responsibility initiatives to support the National Blood Bank. It is heartening to see our staffs turning up enthusiastically to support this noble cause. The display of strength and unity was indeed applaudable. 

Conserving the Environment

Waste Management & Energy Consumption

We are committed to reducing environmental footprint across the value chain, from manufacturing to distribution through recycling, proper water and waste management and increased efficiency in usage of energy while ensuring that the relevant regulations and standards are met.

Sustaining Growth

At Xepa, we strive to deliver long term value for our customers and shareholders. We live up to the highest standards of ethics and governance in our culture and practices.

Our management structure and governance combines responsible leadership and independent supervision.

We operate with the highest standards to ensure product safety for all.

our history

1962
1967
1973
1995
2000
2001
2002
2003
2008
2010
2013
2014
2017
2018
2020
Today

1962

1967

1973

1995

2000

2001

2002

2003

2008

2010

2013

2014

2017

2018

2020

Today

Let’s work together to help people live healthier, longer and more productive lives.